SimonMed Imaging Launches Ultrasound+: AI-Powered Early Cancer Detection Now Accessible Nationwide
(Image Credit: SimonMed)
Early and accurate cancer detection is paramount. Now, a notable leap forward in medical imaging is making that a reality for more patients across the United States.SimonMed Imaging,a leading outpatient imaging provider,has announced the nationwide rollout of ultrasound+,an innovative,AI-enhanced ultrasound program designed to improve breast and thyroid cancer detection rates.
the Challenge of Early Cancer Detection
Traditional ultrasound relies heavily on the radiologist’s expertise.However, subtle indicators of cancer can sometimes be missed, leading to delayed diagnoses. This is where the power of Artificial Intelligence (AI) comes into play. Ultrasound+ isn’t intended to replace skilled radiologists, but to augment thier abilities, acting as a highly trained “second pair of eyes.”
Introducing Ultrasound+: How AI is Transforming Imaging
Ultrasound+ is powered by Koios DS,the only FDA-cleared AI cancer diagnosis software specifically for breast ultrasound images. Developed by Koios Medical, this technology analyzes ultrasound images in real-time, identifying patterns frequently enough imperceptible to the human eye.
here’s how it works:
* Advanced Algorithms: Koios DS is trained on a massive dataset of ultrasound images – millions of data points – allowing it to recognize subtle anomalies indicative of cancerous tissue.
* Real-Time Analysis: The AI analyzes images during the ultrasound exam, providing immediate insights to the radiologist.
* BI-RADS® Categorization: Koios DS Breast classifies suspicious lesions and aligns them with the standardized BI-RADS® (Breast Imaging-Reporting and Data System) categories, ensuring consistent and objective assessment.
* System-Wide Integration: SimonMed has seamlessly integrated Koios DS across all locations offering ultrasound exams, making this technology universally available to their patients.
Benefits for Patients: A New Standard of Care
Ultrasound+ represents a significant advancement in patient care, offering a multitude of benefits. This isn’t just about technology; it’s about peace of mind and improved outcomes.
* Earlier Cancer Detection: AI assistance helps radiologists identify subtle signs of cancer sooner, potentially leading to more effective treatment.
* Reduced False Positives & Needless Biopsies: By providing a more accurate assessment, Ultrasound+ minimizes the need for follow-up imaging and potentially reduces the number of unnecessary biopsies performed. This translates to less patient anxiety and lower healthcare costs.
* Increased Confidence in Results: Patients can feel more confident in their diagnosis, knowing that their images have been analyzed with the aid of cutting-edge AI technology.
* Reimbursable Technology: Ultrasound+ is eligible for insurance reimbursement, making this advanced technology accessible to a wider range of patients.
What This Means for the Future of Medical Imaging
SimonMed’s commitment to integrating AI into its imaging services sets a new nationwide standard. “By making Ultrasound+ available at every location offering ultrasound exams,every patient who comes to SimonMed for a breast or thyroid ultrasound now benefits from AI-enhanced imaging,” explains Dr. John Simon, CEO and founder of SimonMed Imaging. “This reimbursable-eligible technology helps us detect cancers earlier, reduce unnecessary procedures, and ultimately improve outcomes for patients everywhere.”
this launch isn’t just about one company adopting new technology.It signals a broader shift in the medical imaging landscape – a move towards leveraging the power of AI to enhance diagnostic accuracy,improve patient care,and ultimately,save lives.
Learn more about Ultrasound+ and SimonMed Imaging:
* Koios Medical